Post-doctorate

Guideline
The Next Generation of Biomedical and Behavioral Sciences Researchers
These recommendations chart a path to a biomedical research enterprise that is competitive, rigorous, fair, dynamic, and can attract the best minds from across the country.
Τhere is a growing concern that the biomedical research enterprise is beset by several core challenges that undercut its vitality, promise, and productivity and that could diminish its critical role in the nation’s health and innovation in the biomedical industry. Among the most salient of these challenges is the gulf between the burgeoning number of scientists qualified to participate in this system as academic researchers and the elusive opportunities to establish long-term research careers in academia. The patchwork of measures to address the challenges facing young scientists that has emerged over the years has allowed the U.S. biomedical enterprise to continue to make significant scientific and medical advances. These measures, however, have not resolved the structural vulnerabilities in the system, and in some cases come at a great opportunity cost for young scientists. These unresolved issues could diminish the nation’s ability to recruit the best minds from all sectors of the U.S. population to careers in biomedical research and raise concerns about a system that may favor increasingly conservative research proposals over high-risk, innovative ideas. The Next Generation of Biomedical and Behavioral Sciences Researchers: Breaking Through evaluates the factors that influence transitions into independent research careers in the biomedical and behavioral sciences and offers recommendations to improve those transitions.
Reference of the resource
National Academies of Sciences, Engineering, and Medicine. 2018. The Next Generation of Biomedical and Behavioral Sciences Researchers: Breaking Through. Washington, DC: The National Academies Press. https://doi.org/10.17226/25008.
Topic:
Research integrity training
Subopic:
Post-doctorate
Type of resource:
Guideline
Relevant discipline(s):
Medical science (incl. biomedicine)
Relevant stakeholder(s):
All stakeholders of scientific research
Relevant organisational level(s):
System (macro level)
Institution (meso level)
Published/put into force:
2018